Citation: E. Hermans et Raj. Challiss, Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors, BIOCHEM J, 359, 2001, pp. 465-484
Authors:
Nash, MS
Young, KW
Willars, GB
Challiss, RAJ
Nahorski, SR
Citation: Ms. Nash et al., Single-cell imaging of graded Ins(1,4,5)P-3 production following G-protein-coupled-receptor activation, BIOCHEM J, 356, 2001, pp. 137-142
Authors:
Selkirk, JV
Price, GW
Nahorski, SR
Challiss, RAJ
Citation: Jv. Selkirk et al., Cell type-specific differences in the coupling of recombinant mGlu1 alpha receptors to endogenous G protein sub-populations, NEUROPHARM, 40(5), 2001, pp. 645-656
Authors:
Willets, JM
Challiss, RAJ
Kelly, E
Nahorski, SR
Citation: Jm. Willets et al., G protein-coupled receptor kinases 3 and 6 use different pathways to desensitize the endogenous M-3 muscarinic acetylcholine receptor in human SH-SY5Y cells, MOLEC PHARM, 60(2), 2001, pp. 321-330
Authors:
Nash, MS
Saunders, R
Young, KW
Challiss, RAJ
Nahorski, SR
Citation: Ms. Nash et al., Reassessment of the Ca2+ sensing property of a type I metabotropic glutamate receptor by simultaneous measurement of inositol 1,4,5-trisphosphate andCa2+ in single cells, J BIOL CHEM, 276(22), 2001, pp. 19286-19293
Citation: Ec. Akam et al., G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype, BR J PHARM, 132(4), 2001, pp. 950-958
Authors:
de Kort, M
Regenbogen, AD
Overkleeft, HS
Challiss, RAJ
Iwata, Y
Miyamoto, S
van der Marel, GA
van Boom, JH
Citation: M. De Kort et al., Synthesis and biological evaluation of cyclophostin: A 5 ',6 ''-tethered analog of adenophostin A, TETRAHEDRON, 56(32), 2000, pp. 5915-5928
Authors:
Hermans, E
Saunders, R
Selkirk, JV
Mistry, R
Nahorski, SR
Challiss, RAJ
Citation: E. Hermans et al., Complex involvement of pertussis toxin-sensitive G proteins in the regulation of type 1 alpha metabotropic glutamate receptor signaling in baby hamster kidney cells, MOLEC PHARM, 58(2), 2000, pp. 352-360
Citation: E. Hermans et al., Heterologous mammalian expression systems for investigating the propertiesof metabotropic glutamate receptors, BIOCH SOC T, 27(2), 1999, pp. 164-170
Authors:
Young, KW
Challiss, RAJ
Nahorski, SR
Mackrill, JJ
Citation: Kw. Young et al., Lysophosphatidic acid-mediated Ca2+ mobilization in human SH-SY5Y neuroblastoma cells is independent of phosphoinositide signalling, but dependent onsphingosine kinase activation, BIOCHEM J, 343, 1999, pp. 45-52
Citation: Rj. Davis et al., Enhanced purinoceptor-mediated Ca2+ signalling in L-fibroblasts overexpressing type 1 inositol 1,4,5-trisphosphate receptors, BIOCHEM J, 341, 1999, pp. 813-820
Citation: Pg. Wylie et al., Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors, BIOCHEM J, 338, 1999, pp. 619-628
Authors:
Mody, N
Hermans, E
Nahorski, SR
Challiss, RAJ
Citation: N. Mody et al., Inhibition of N-linked glycosylation of the human type 1 alpha metabotropic glutamate receptor by tunicamycin: effects on cell-surface receptor expression and function, NEUROPHARM, 38(10), 1999, pp. 1485-1492
Authors:
Budd, DC
Challiss, RAJ
Young, KW
Tobin, AB
Citation: Dc. Budd et al., Cross talk between m3-muscarinic and beta(2)-adrenergic receptors at the level of receptor phosphorylation and desensitization, MOLEC PHARM, 56(4), 1999, pp. 813-823
Authors:
Holland, M
Challiss, RAJ
Standen, NB
Boyle, JP
Citation: M. Holland et al., Cannabinoid CB1 receptors fail to cause relaxation, but couple via G(i)/G(o) to the inhibition of adenylyl cyclase in carotid artery smooth muscle, BR J PHARM, 128(3), 1999, pp. 597-604
Citation: E. Hermans et al., Effects of varying the expression level of recombinant human mGlu1 alpha receptors on the pharmacological properties of agonists and antagonists, BR J PHARM, 126(4), 1999, pp. 873-882
Authors:
Wilcox, RA
Primrose, WU
Nahorski, SR
Challiss, RAJ
Citation: Ra. Wilcox et al., New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor (vol 19, pg 467, 1998), TRENDS PHAR, 19(12), 1998, pp. 486-486
Citation: E. Hermans et al., Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1 alpha metabotropic glutamate receptor, NEUROPHARM, 37(12), 1998, pp. 1645-1647